Brain Dead Diagnosis and Treatment Market Research Report-  Global  Forecast till 2030

Brain Dead Diagnosis & Treatment Market Research Report Information By Diagnosis Type (Physical Examination, Blood Test, Brain Scans) Brain Scans (CT, MRI, EEG) Treatment (Medical Treatment) End User (Hospitals & Clinics, Research Laboratories) - Global Forecast till 2030

ID: MRFR/Pharma/3562-HCR | 100 Pages | Author: Rahul Gotadki | March 2024         

Brain Dead Diagnosis and Treatment Market Speak to Analyst Request a Free Sample

Brain Dead Diagnosis and Treatment Market Scenario


The Brain Dead Diagnosis and Treatment Market is projected to reach USD 5,853.18 Million by 2030 at 6.6% CAGR during the forecast period 2022-2030.Brain death is the total and irreversible loss of all brain functions and the circumstance under which the donation of vital organs most commonly takes place. Brain death occurs when a person has a catastrophic brain injury leading to total cessation of all brain function including the upper brain structure and brain stem. Brain death is not a coma or persistent vegetative state. Brain death is determined in the hospital by one or more physicians not associated with a transplantation team.


The increasing incidence of accidents and brain injury is leading to shift from treatment to oragn donation procedures are some factors responsible for the growth of the  brain dead diagnosis and treatment market.


A brain-dead patient is supposed to have no clinical evidence of brain function upon physical examination. The examination exhibits no cranial nerve reflexes and no response to pain. The reflexes include no spontaneous respirations, oculocephalic reflex, pupillary response (fixed pupils), corneal reflex, and no response to the caloric reflex test. According to the World Health Organization estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


It is of utmost important to distinguish brain death and other states that may be difficult to differentiate from brain death, such as alcohol intoxication, chronic vegetative states, barbiturate overdose, hypoglycemia, hypothermia, coma, and sedative overdose. Few comatose patients can recover to pre-coma level of functioning, and some patients with severe irreversible neurological dysfunction will nonetheless retain some lower brain functions, such as spontaneous respiration, despite the losses of both cortex and brain stem functionality in case of anencephaly. However, limited availability of facilities and higher treatment cost may hamper the Brain Dead Diagnosis and Treatment Market growth during the forecast period.


Intended Audience



  • Brain Dead Diagnosis and Treatment Suppliers

  • Brain Dead Diagnosis and Treatment Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Segmentation


The brain dead diagnosis and treatment market is segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of diagnosis, it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG), radionuclide angiography, cerebral arteriography, nuclear brain scanning, transcranial doppler ultrasonography


On the basis of treatment, it is segmented into medical treatment, and others.


On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.


Regional Analysis


The brain dead diagnosis and treatment market consists of countries namely America, Europe, Asia Pacific, and the Middle East.


North America dominated the brain dead diagnosis and treatment market owing to the increasing healthcare expenditure. In the United States, if the patient is at or near death, the hospital must notify a transplant organization of the person's details and maintain the patient while the patient is being evaluated for suitability as a donor. The patient is kept on ventilator support until the organs have been surgically removed. Furthermore, increased R&D activities and the concentration of major companies have fueled the growth of the market in this region.


Europe holds the second position in the brain dead diagnosis and treatment market owing to the government support for research & development and availability of funds for research. For instace, in countries such as Spain, Finland, Poland, Wales, Portugal, and France, everyone is automatically an organ donor after diagnosis of death on legally accepted criteria, although some jurisdictions such as Singapore, Spain, Wales, France, Czech Republic and Portugal allow opting out of the system. Elsewhere, consent from family members or next-of-kin may be mandatory for organ donation.


Asia Pacific is the fastest growing brain dead diagnosis and treatment market owing to the presence of rapidly developing healthcare technology, increasing stressful life, and high healthcare expenditure. Moreover, increasing patient population in countries such as New Zealand, Australia, drivers are asked upon application if they wish to be registered as an organ donor are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the Brain Dead Diagnosis and Treatment Market growth in this region. 


Furthermore in the Middle East & Africa the spending for healthcare was also increased. The Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Key Players


Some of key the players in the Brain dead diagnosis and Treatment Market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others


Research Methodology Brain Dead Diagnosis and Treatment Market


Sources: Annual reports, Press release, White paper, and Company presentation


 



Frequently Asked Questions (FAQ) :

Brain dead diagnosis and treatment market is projected to grow at approximately 6.6% CAGR during the assessment period (2022-2030).

The increasing incidence of accidents and brain injuries are the major tailwinds pushing the growth of the global brain dead diagnosis and treatment market.

Limited availability of facilities and high cost of treatments are major growth detriments for the global brain dead diagnosis and treatment market.

North America holds the largest share in the global brain dead diagnosis and treatment market, followed by Europe and the Asia Pacific, respectively.

GE Healthcare (U.S.), Fujifilm Holdings (Japan), Siemens Healthcare(U.S.), Shimadzu Corporation (Japan), Philips Healthcare (U.S.), Toshiba Medical Systems Corporation (Japan), Nihon Kohden Corporation (Japan), Carestream Health (U.S.), Electrical Geodesics Inc. (U.S.), Hologic (U.S.), Masimo Corporation (U.S.), and Esaote (Italy), are some of the top players operating in the global brain dead diagnosis and treatment market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid